Lei Wang

14.3k citations
417 papers · 11.8k · 2 hit papers · h-index 55

Impact in

  • Biomaterials top 0.2%
    • Supramolecular Self-Assembly in Materials
    • Nanoparticle-Based Drug Delivery
    • Nanoplatforms for cancer theranostics
    • Bone Tissue Engineering Materials
    • Graphene and Nanomaterials Applications

Papers in

    • Supramolecular Self-Assembly in Materials 45
    • Nanoparticle-Based Drug Delivery 17
    • Peptidase Inhibition and Analysis 30

Lei Wang

394 papers receiving 11.4k citations

Lei Wang's Hit Papers

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study 2023 · 210 citations
2100+2+5Years since publication100200300400

Peers

Lei Wang
Comparison fields: 5 of 167
  • Biomaterials 2.7k
  • Biomedical Engineering 3.6k
  • Microbiology 387
  • Molecular Biology 3.7k
  • Molecular Medicine 266
Replace Jianqing Gao with:
Jianqing Gao China
Thomas Lars Andresen Denmark
Yang Liu China
Jiacan Su China
Dan Shao China
Deling Kong China
Zhiqing Pang China
Yucai Wang China
Yunfeng Lin China
Yin Wang China
Lei Wang relative to Jianqing Gao China Jianqing Gao's profile →
Citations per field
00.5×1.6×
Jianqing Gao · 1×
Citations per year

Countries citing papers authored by Lei Wang

Since Specialization
Citations

This map shows the geographic impact of Lei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wang more than expected).

Fields of papers citing papers by Lei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wang. The network helps show where Lei Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lei Wang Line = papers co-authored together Lei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 417 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003492
2
Self‐Assembled Peptide‐Based Nanomaterials for Biomedical Imaging and Therapy
Hit paper breakdown →
2018472
3 2003271
4 2013262
5 2020236
6 2014226
7 2016223
8
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2023210
9 2017188
10 2018177
11 2018169
12 2019165
13 2014162
14 2017152
15 2022151
16 2018149
17 2020144
18 2020141
19 2019138
20 2015134

About Lei Wang

Lei Wang is a scholar working on Biomaterials, Oncology, Biomedical Engineering, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 417 papers that have together received 11.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (56 papers), Supramolecular Self-Assembly in Materials (45 papers), Peptidase Inhibition and Analysis (30 papers), Monoclonal and Polyclonal Antibodies Research (25 papers), Luminescence and Fluorescent Materials (24 papers), Bone Tissue Engineering Materials (19 papers), Advanced biosensing and bioanalysis techniques (17 papers) and Nanoparticle-Based Drug Delivery (17 papers). The work is most often cited by research in Biomaterials (2.7k citations), Biomedical Engineering (3.6k citations), Microbiology (387 citations), Molecular Biology (3.7k citations) and Molecular Medicine (266 citations). Lei Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hao Wang, Yujuan Gao, Guobin Qi, Pei‐Pei Yang, Jingping Zhang, Michael Chopp, Kuo Zhang, Zeng‐Ying Qiao, Jieli Chen and Yao‐Xin Lin. Their work appears in journals such as Small, Biomaterials, Chinese Chemical Letters, Advanced Materials and Journal of Materials Chemistry B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact